Wednesday, June 10, 2026

Drug profile · INN

olodaterol

olodaterol is a beta-2 adrenergic receptor agonist.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — olodaterol
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

olodaterol is a beta-2 adrenergic receptor agonist.

Key facts

INN olodaterol
Mechanism Beta-2 adrenergic receptor agonist

Mechanism of action

Beta-2 adrenergic receptor agonist

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Olodaterol (BI 1744) Phase 3 · Boehringer Ingelheim · Pulmonary Disease, Chronic Obstructive
  2. tiotropium + olodaterol Phase 3 · Boehringer Ingelheim · Pulmonary Disease, Chronic Obstructive

Frequently asked questions

What is olodaterol?

olodaterol is a beta-2 adrenergic receptor agonist.